Rituxan (rituximab) - Roche
Primary bladder diffuse large B-cell lymphoma causing unilateral ureterovesical junction obstruction: A case report. (PubMed, Urol Case Rep) - Oct 15, 2026 - "Transurethral resection plus R-CHOP chemotherapy produced complete metabolic response on FDG-PET/CT, with stable residual uptake later deemed post-treatment change (Deauville 3). This case highlights ureteral obstruction as an unusual presentation and serial PET/CT as valuable for distinguishing residual lymphoma from fibrosis after therapy." 
Journal • B Cell Lymphoma • Diffuse Large B Cell Lymphoma • Fibrosis • Hematological Malignancies • Immunology • Lymphoma • Non-Hodgkin's Lymphoma • Oncology • Pain • Solid Tumor • Urothelial Cancer
http://www.ncbi.nlm.nih.gov/pubmed/42871637
 
Farshad Banouei; Maryam Abolhasani; Mostafa Rajabi; Reza Kaffash Nayeri
 
Oct 15, 2026
 
Prev Next